For primary care physicians, the question is increasingly whether continuous glucose data could answer a clinically useful ...

The US Food and Drug Administration (FDA) has granted Breakthrough Device designation to Natera's multi-cancer early ...

A gap between perceived and actual risk, messaging that has not reached women, and long drive times to a prescriber all limit ...

Adolescents and young adults with sporadic colorectal cancer (CRC) most often present with stage III or IV disease, and only ...

Every clinician can prescribe or refer for PrEP. The faculty outline the education, team structures, and community outreach ...

Freenome reports 18.2% sensitivity for advanced precancerous lesions and 80.4% for colorectal cancer with its updated blood ...

Pauline M. Maki, PhD, introduces OPTION-VMS and explains why real-world data are needed to test whether randomized trial ...

Pauline M. Maki, PhD, reviews the first data cuts from OPTION-VMS, released at The Menopause Society 2025 meeting. These ...

FDA has granted IDE approval for the STROKE-REWIRE pivotal trial evaluating NeuWire Medical's neurostimulation device for ...

FDA approves olanzapine, a once-monthly subcutaneous injection for adults with schizophrenia, boosting symptom control while ...

In "Shared Decision-Making for Agitation in Specialty Care and Disease Trajectory," our experts close out the discussion of ...

A multicomponent approach to vaccination distress works across the lifespan, though how it works depends on age, according to ...